World’s

Most Adopted

Healthcare AI

25M+
Lives impacted
 to date
90+
Countries via 3100+ sites
1B+
Training datasets
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
Fujifilm.webp
image 187.webp
image 387.webp
image 193.webp
Philips_logo_new 1.webp
image 269.webp
Blackford-Logo-New-(0411-V0D)---3 2.webp
image 267.webp
image 268.webp
astra-zeneca-website.webp
14 Siemens.webp
image 160.webp
Medtronic-Logo.webp
image 406.webp
image 409.webp
image 407.webp
GDPR
Transforming Healthcare Pathways with AI
Global Health.webp
Global Health.webp
Advancing Public Health Access for Tuberculosis, Pediatric TB & Beyond
WHO-evaluated AI solutions to support clinicians in making quick and accurate diagnosis and treatment decisions. This provides global access to Tuberculosis, Silicosis, and Pediatric Tuberculosis care and real-time disease surveillance. 
See How
Lung Cancer.webp
Lung Cancer.webp
Accelerating Early Detection & Management of Lung Cancer
The end-to-end Lung Cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians, improving outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
See How
Stroke.webp
Stroke.webp
Enabling Timely Intervention in Stroke Care
An AI-powered care coordination suite to enable patient triage, ensuring seamless clinical coordination with real-time communication. It supports Hub & Spoke networks to facilitate timely stroke interventions by clinicians, anywhere. 
See How
The Global Impact of AI: Real Stories, 
Real Lives Transformed
From Aims to Achievements: Fulfilling Clinical & Business Goals
Explore Our Latest Developments 
AI Helps Doctors Treat Stroke Faster: Qure.ai Study Reveals Significant Real-World Impact
Read Study
Justy Antony Chiramal , Jacob Johnson, Jemin Webster, D. Rachel Nag, Dennis Robert, Tamaghna Ghosh, Satish Golla, Saniya Pawar, Pranav Krishnan, Paul K. Drain, Stephen J. Mooney 
See More Evidence

“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”

Leif Johannsson

Chairman at AstraZeneca

Leif Johannsson .webp

“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."

Michael Blackwell

President and Managing Director at Medtronic India

Michael Blackwell .webp

“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”

David M. Rubin

Managing Director at Merck Global Health Innovation Fund LLC

David Rubin – Merck.webp

”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating  Qure.ai  with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”

Llang Bridget M. Maama-Maime

National TB Programme Manager at Ministry of Health, Lesotho

Llang Bridget M. Maama-Maime.webp

“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”

Prof. David Baldwin

Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham

Prof. David Baldwin .webp

“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”

Dr. Seraphine Kaminsa

Senior Technical Tuberculosis Advisor at Save The Children US

Dr. Seraphine Kaminsa.webp

“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”

Prof. David Lowe

Professor of Health Innovation at University of Glasgow

Prof David lowe.webp

"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."

Andrew Cannon

Chief Executive Officer at Medica Group

Andrew Cannon.webp
qTrack
AI-powered reporting and seamless collaboration platform offers an end-to-end solution for screening programs and case management. qTrack enables enhanced care coordination and monitors program health developments through customized dashboards. 
qTrack -2.webp